Illumina · 22 hours ago
Senior Manager, Investor Relations (San Diego/Hybrid)
Illumina is a company focused on expanding access to genomic technology for health equity. The Senior Manager, Investor Relations will lead investor relations activities, collaborating with executive management to engage with the investment community and oversee various IR initiatives.
BiotechnologyGeneticsHealth CareMedical
Responsibilities
Lead cross-functional execution of earnings, investor days, and other major investor-facing deliverables
Lead development of financial content, executive remarks, presentations, Q&A, and supporting materials
Collaborate with cross-functional teams to align and approve materials prior to release
Oversee accurate and timely publication of IR materials to internal and external distribution channels
Participate in meetings with investors and sell-side analysts, representing the company with credibility and accuracy
Synthesize investor feedback, analyst commentary, and market sentiment, ensuring insights are elevated for management and the Board
Guide peer benchmarking, disclosure analysis, and equity research review to assess competitive positioning and evolving investor expectations
Oversee investor targeting strategy and quarterly shareholder ownership analysis, focusing on composition, trends, and implications
Oversee day-to-day IR operations by setting priorities, improving workstreams, and ensuring accountability across the team
Provide direction and escalation support to junior team members, ensuring consistency, quality, and development of team output
Manage relationships with vendors and external partners
Serve as a cross-functional partner to maintain alignment on messaging, data integrity, and disclosure controls
Drive continuous improvement of IR processes, tools, and workflows
Qualification
Required
Typically requires a minimum of 12 years of related finance experience with a bachelor's degree, including 3-6 years in a management capacity, or an equivalent combination of education and experience
Background in investor relations, investment banking, or equity research
Demonstrated ability to manage projects, coordinate cross-functional deliverables, and oversee work from junior team members
Experience preparing and reviewing executive and external-facing materials
Experience engaging with the investment community strongly preferred
Experience translating scientific content into investor messaging strongly preferred
Strong financial acumen with ability to interpret financial models, company financial statements, and market data, applying knowledge to convince stakeholders on desired outcomes
Excellent organizational and project management skills with the ability to persuade others in sensitive and complex situations while preserving relationships
Advanced proficiency in Excel (e.g., pivot tables, INDEX/MATCH, XLOOKUP) and PowerPoint
Familiarity with financial software platforms (e.g., Nasdaq IR Insight, FactSet, Bloomberg)
Knowledge of data interpretation software (e.g., Tableau) and proven ability implementing AI tools into workflows
Exceptional written and verbal communication skills
Strong attention to detail, accountability, and responsiveness, with a proactive approach to problem solving and process improvement
Must be able to travel domestically and internationally up to 10% of the time. A valid passport is required and/or additional documentation (e.g., travel visas) may be necessary based on destination-specific requirements
Preferred
Experience engaging with the investment community strongly preferred
Experience translating scientific content into investor messaging strongly preferred
Benefits
Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off
Company
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Funding
Current Stage
Public CompanyTotal Funding
$1.28BKey Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO
Leadership Team
Recent News
2026-01-09
2026-01-09
2026-01-09
Company data provided by crunchbase